The EVERY Company, a pioneer in precision fermentation for egg proteins, has announced a $55 million Series D round, led by McWin Capital Partners.
“We had a target of raising $50 million and ended up closing in on $55 million,” said founder and CEO Arturo Elizondo.
The funding will help EVERY expand manufacturing capacity and move to profitability, with products featuring its proteins set to roll out across the US at Walmart.
Author's summary: EVERY Co raises $55m for egg protein production.